Hers vs Shed: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Shed scores higher on our rubric, 7.8/10 against 7.3/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Shed - our pick of these two →or find your match

Shed beats Hers overall, scoring 7.8/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Shed is from $199/mo. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path. Choose Shed for users who want fast delivery and a streamlined compounded glp-1 experience.

A side-by-side look at Hers and Shed to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Hers

#30 of 54

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.

Visit Hers

Higher Rated

Shed

#12 of 54

7.8/10

Newer GLP-1 provider focused on speed and simplicity, fast approvals, fast shipping, and a clean user experience at a competitive price point.

Visit Shed

Feature	Hers	Shed
Why each one	A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options.	The fastest GLP-1 delivery in the market, from signup to medication-in-hand in 2-3 days, with a streamlined experience that eliminates unnecessary friction.
Our Score	7.3/10	7.8/10
Headline Price	$188 first month, then $298/mo	from $199/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path	Users who want fast delivery and a streamlined compounded GLP-1 experience
Watch out for	Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.	The core $199 program is compounded semaglutide and tirzepatide; brand-name access runs through a separate $99/mo pathway subscription with medication billed at pharmacy rates on top
Ranking	#30	#12
Get started	Visit Hers	Visit Shed

Pros & Cons Compared

Hers

Pros

+FDA-approved brand paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199; with the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services

Cons

−Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
−Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
−Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
−Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
−Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher

Shed

Pros

+Industry-leading delivery speed, most patients receive medication within 2-3 days of enrollment
+$199/mo is competitively priced for an all-inclusive compounded program with good support
+Streamlined onboarding with no video call, approved and shipped faster than most competitors
+Clean, modern UX with real-time shipping tracking and easy provider messaging

Cons

−The core $199 program is compounded semaglutide and tirzepatide; brand-name access runs through a separate $99/mo pathway subscription with medication billed at pharmacy rates on top
−Newer company (founded 2024) with limited long-term track record and outcome data; the 4.6/5 Trustpilot rating across 766 reviews is the strongest early evidence available
−No insurance billing and no FSA/HSA superbills currently available
−Clinical support is responsive (replies typically within 24 hours) but less proactive than premium platforms; a $49.99/mo premium coaching add-on covers those who want higher touch

Our Verdict

Shed edges out Hers with a score of 7.8/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Shed is from $199/mo.